Quality of life scores at baseline (week 0) and end of chemotherapy (week 18) in the DHA and placebo groups.
<p>Quality of life scores at baseline (week 0) and end of chemotherapy (week 18) in the DHA and placebo groups.</p>
Saved in:
| Main Author: | |
|---|---|
| Other Authors: | , , , , , , |
| Published: |
2025
|
| Subjects: | |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1852020817854988288 |
|---|---|
| author | Claire M. Douglas (21238238) |
| author2 | Marnie Newell (11631607) Susan Goruk (7343036) Kerry S. Courneya (7238747) Sunita Ghosh (102512) Anil A. Joy (4336462) Jaqueline Munhoz (9901827) Catherine J. Field (6706901) |
| author2_role | author author author author author author author |
| author_facet | Claire M. Douglas (21238238) Marnie Newell (11631607) Susan Goruk (7343036) Kerry S. Courneya (7238747) Sunita Ghosh (102512) Anil A. Joy (4336462) Jaqueline Munhoz (9901827) Catherine J. Field (6706901) |
| author_role | author |
| dc.creator.none.fl_str_mv | Claire M. Douglas (21238238) Marnie Newell (11631607) Susan Goruk (7343036) Kerry S. Courneya (7238747) Sunita Ghosh (102512) Anil A. Joy (4336462) Jaqueline Munhoz (9901827) Catherine J. Field (6706901) |
| dc.date.none.fl_str_mv | 2025-05-02T17:32:34Z |
| dc.identifier.none.fl_str_mv | 10.1371/journal.pone.0322178.t002 |
| dc.relation.none.fl_str_mv | https://figshare.com/articles/dataset/Quality_of_life_scores_at_baseline_week_0_and_end_of_chemotherapy_week_18_in_the_DHA_and_placebo_groups_/28922594 |
| dc.rights.none.fl_str_mv | CC BY 4.0 info:eu-repo/semantics/openAccess |
| dc.subject.none.fl_str_mv | Medicine Cell Biology Physiology Pharmacology Biotechnology Immunology Cancer Science Policy Biological Sciences not elsewhere classified Chemical Sciences not elsewhere classified resistance training frequency polyunsaturated fatty acids adequately powered studies meeting exercise guidelines aerobic exercise volume xlink "> supplementation reduced side effects metastatic breast cancer evaluate docosahexaenoic acid 4 &# 8201 significantly affect qol current exploratory study dha supplementation improves women undergoing nac docosahexaenoic acid current study breast cancer exploratory outcomes exercise decreased exercise behaviour exercise ), dha supplementation two indices supportive care supplementing women six cycles significantly lower potential therapies measure qol may mitigate better qol administered questionnaires 8 minutes 57 times 49 ). |
| dc.title.none.fl_str_mv | Quality of life scores at baseline (week 0) and end of chemotherapy (week 18) in the DHA and placebo groups. |
| dc.type.none.fl_str_mv | Dataset info:eu-repo/semantics/publishedVersion dataset |
| description | <p>Quality of life scores at baseline (week 0) and end of chemotherapy (week 18) in the DHA and placebo groups.</p> |
| eu_rights_str_mv | openAccess |
| id | Manara_2f0a8564f90f8bd8dbf8828a6fb30849 |
| identifier_str_mv | 10.1371/journal.pone.0322178.t002 |
| network_acronym_str | Manara |
| network_name_str | ManaraRepo |
| oai_identifier_str | oai:figshare.com:article/28922594 |
| publishDate | 2025 |
| repository.mail.fl_str_mv | |
| repository.name.fl_str_mv | |
| repository_id_str | |
| rights_invalid_str_mv | CC BY 4.0 |
| spelling | Quality of life scores at baseline (week 0) and end of chemotherapy (week 18) in the DHA and placebo groups.Claire M. Douglas (21238238)Marnie Newell (11631607)Susan Goruk (7343036)Kerry S. Courneya (7238747)Sunita Ghosh (102512)Anil A. Joy (4336462)Jaqueline Munhoz (9901827)Catherine J. Field (6706901)MedicineCell BiologyPhysiologyPharmacologyBiotechnologyImmunologyCancerScience PolicyBiological Sciences not elsewhere classifiedChemical Sciences not elsewhere classifiedresistance training frequencypolyunsaturated fatty acidsadequately powered studiesmeeting exercise guidelinesaerobic exercise volumexlink "> supplementationreduced side effectsmetastatic breast cancerevaluate docosahexaenoic acid4 &# 8201significantly affect qolcurrent exploratory studydha supplementation improveswomen undergoing nacdocosahexaenoic acidcurrent studybreast cancerexploratory outcomesexercise decreasedexercise behaviourexercise ),dha supplementationtwo indicessupportive caresupplementing womensix cyclessignificantly lowerpotential therapiesmeasure qolmay mitigatebetter qoladministered questionnaires8 minutes57 times49 ).<p>Quality of life scores at baseline (week 0) and end of chemotherapy (week 18) in the DHA and placebo groups.</p>2025-05-02T17:32:34ZDatasetinfo:eu-repo/semantics/publishedVersiondataset10.1371/journal.pone.0322178.t002https://figshare.com/articles/dataset/Quality_of_life_scores_at_baseline_week_0_and_end_of_chemotherapy_week_18_in_the_DHA_and_placebo_groups_/28922594CC BY 4.0info:eu-repo/semantics/openAccessoai:figshare.com:article/289225942025-05-02T17:32:34Z |
| spellingShingle | Quality of life scores at baseline (week 0) and end of chemotherapy (week 18) in the DHA and placebo groups. Claire M. Douglas (21238238) Medicine Cell Biology Physiology Pharmacology Biotechnology Immunology Cancer Science Policy Biological Sciences not elsewhere classified Chemical Sciences not elsewhere classified resistance training frequency polyunsaturated fatty acids adequately powered studies meeting exercise guidelines aerobic exercise volume xlink "> supplementation reduced side effects metastatic breast cancer evaluate docosahexaenoic acid 4 &# 8201 significantly affect qol current exploratory study dha supplementation improves women undergoing nac docosahexaenoic acid current study breast cancer exploratory outcomes exercise decreased exercise behaviour exercise ), dha supplementation two indices supportive care supplementing women six cycles significantly lower potential therapies measure qol may mitigate better qol administered questionnaires 8 minutes 57 times 49 ). |
| status_str | publishedVersion |
| title | Quality of life scores at baseline (week 0) and end of chemotherapy (week 18) in the DHA and placebo groups. |
| title_full | Quality of life scores at baseline (week 0) and end of chemotherapy (week 18) in the DHA and placebo groups. |
| title_fullStr | Quality of life scores at baseline (week 0) and end of chemotherapy (week 18) in the DHA and placebo groups. |
| title_full_unstemmed | Quality of life scores at baseline (week 0) and end of chemotherapy (week 18) in the DHA and placebo groups. |
| title_short | Quality of life scores at baseline (week 0) and end of chemotherapy (week 18) in the DHA and placebo groups. |
| title_sort | Quality of life scores at baseline (week 0) and end of chemotherapy (week 18) in the DHA and placebo groups. |
| topic | Medicine Cell Biology Physiology Pharmacology Biotechnology Immunology Cancer Science Policy Biological Sciences not elsewhere classified Chemical Sciences not elsewhere classified resistance training frequency polyunsaturated fatty acids adequately powered studies meeting exercise guidelines aerobic exercise volume xlink "> supplementation reduced side effects metastatic breast cancer evaluate docosahexaenoic acid 4 &# 8201 significantly affect qol current exploratory study dha supplementation improves women undergoing nac docosahexaenoic acid current study breast cancer exploratory outcomes exercise decreased exercise behaviour exercise ), dha supplementation two indices supportive care supplementing women six cycles significantly lower potential therapies measure qol may mitigate better qol administered questionnaires 8 minutes 57 times 49 ). |